AbbVie Inc. (FRA:4AB)
169.80
-2.00 (-1.16%)
At close: Aug 13, 2025, 10:00 PM CET
AbbVie Employees
AbbVie had 55,000 employees as of December 31, 2024. The number of employees increased by 5,000 or 10.00% compared to the previous year.
Employees
55,000
Change (1Y)
5,000
Growth (1Y)
10.00%
Revenue / Employee
$903,023
Profits / Employee
$57,639
Market Cap
300.59B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 55,000 | 5,000 | 10.00% |
Dec 31, 2023 | 50,000 | 0 | - |
Dec 31, 2022 | 50,000 | 0 | - |
Dec 31, 2021 | 50,000 | 3,000 | 6.38% |
Dec 31, 2020 | 47,000 | 17,000 | 56.67% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
SAP SE | 109,121 |
Siemens Aktiengesellschaft | 327,000 |
Deutsche Telekom AG | 198,194 |
Allianz SE | 156,626 |
Siemens Energy AG | 98,000 |
Rheinmetall AG | 28,539 |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
Deutsche Bank Aktiengesellschaft | 89,753 |
AbbVie News
- 13 hours ago - My Dividend Stock Portfolio: New July Dividend Record - 100 Holdings With 12 Buys - Seeking Alpha
- 1 day ago - AbbVie: H1 2025 Earnings Strengthen Case For Targeting Gilgamesh Acquisition - Seeking Alpha
- 1 day ago - AbbVie to invest $195M to build plant in Illinois - Seeking Alpha
- 1 day ago - AbbVie Announces $195 Million Investment to Expand Active Pharmaceutical Ingredient Manufacturing in the U.S. - PRNewsWire
- 4 days ago - Insider Transactions Highlight AbbVie (ABBV) Executive's Stock Sale - GuruFocus
- 4 days ago - Insider trades: AbbVie, Coca Cola , Roblox among notable names this week - Seeking Alpha
- 5 days ago - AbbVie Inclusion In Medicare Drug Talks Fails To Justify Lawsuit, Court Rules - Benzinga
- 5 days ago - Genmab/AbbVie Partnered Blood Cancer Combination Drug Cuts Risk Of Disease Progression By 79% - Benzinga